207 related articles for article (PubMed ID: 23046018)
1. Genetic counseling in melanoma.
Badenas C; Aguilera P; Puig-Butillé JA; Carrera C; Malvehy J; Puig S
Dermatol Ther; 2012; 25(5):397-402. PubMed ID: 23046018
[TBL] [Abstract][Full Text] [Related]
2. Association Between Confocal Morphologic Classification and Clinical Phenotypes of Multiple Primary and Familial Melanomas.
Grazziotin TC; Alarcon I; Bonamigo RR; Carrera C; Potrony M; Aguilera P; Puig-Butillé JA; Brito J; Badenas C; Alós L; Malvehy J; Puig S
JAMA Dermatol; 2016 Oct; 152(10):1099-1105. PubMed ID: 27579522
[TBL] [Abstract][Full Text] [Related]
3. Improvement of Genetic Testing for Cutaneous Melanoma in Countries With Low to Moderate Incidence: The Rule of 2 vs the Rule of 3.
Delaunay J; Martin L; Bressac-de Paillerets B; Duru G; Ingster O; Thomas L
JAMA Dermatol; 2017 Nov; 153(11):1122-1129. PubMed ID: 28903138
[TBL] [Abstract][Full Text] [Related]
4. [Genetic counseling and DNA testing in patients with increased risks for malignant melanoma].
Itin PH; Fistarol SK
Ther Umsch; 2003 Aug; 60(8):469-72. PubMed ID: 14502854
[TBL] [Abstract][Full Text] [Related]
5. Clinical genetic testing for familial melanoma in Italy: a cooperative study.
Bruno W; Ghiorzo P; Battistuzzi L; Ascierto PA; Barile M; Gargiulo S; Gensini F; Gliori S; Guida M; Lombardo M; Manoukian S; Menin C; Nasti S; Origone P; Pasini B; Pastorino L; Peissel B; Pizzichetta MA; Queirolo P; Rodolfo M; Romanini A; Scaini MC; Testori A; Tibiletti MG; Turchetti D; Leachman SA; Bianchi Scarrà G;
J Am Acad Dermatol; 2009 Nov; 61(5):775-82. PubMed ID: 19500876
[TBL] [Abstract][Full Text] [Related]
6. Clinical applications of melanoma genetics.
Gabree M; Patel D; Rodgers L
Curr Treat Options Oncol; 2014 Jun; 15(2):336-50. PubMed ID: 24652319
[TBL] [Abstract][Full Text] [Related]
7. Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.
van der Rhee JI; Krijnen P; Gruis NA; de Snoo FA; Vasen HFA; Putter H; Kukutsch NA; Bergman W
J Am Acad Dermatol; 2011 Aug; 65(2):281-288. PubMed ID: 21570156
[TBL] [Abstract][Full Text] [Related]
8. Molecular landscape of Hereditary Melanoma.
Ribeiro Moura Brasil Arnaut J; Dos Santos Guimarães I; Evangelista Dos Santos AC; de Moraes Lino da Silva F; Machado JR; de Melo AC
Crit Rev Oncol Hematol; 2021 Aug; 164():103425. PubMed ID: 34245855
[TBL] [Abstract][Full Text] [Related]
9. Familial Melanoma Associated with Li-Fraumeni Syndrome and Atypical Mole Syndrome: Total-body Digital Photography, Dermoscopy and Confocal Microscopy.
Giavedoni P; Ririe M; Carrera C; Puig S; Malvehy J
Acta Derm Venereol; 2017 Jun; 97(6):720-723. PubMed ID: 28218344
[TBL] [Abstract][Full Text] [Related]
10. Genetic testing in familial melanoma: uptake and implications.
de Snoo FA; Riedijk SR; van Mil AM; Bergman W; ter Huurne JA; Timman R; Bertina W; Gruis NA; Vasen HF; van Haeringen A; Breuning MH; Tibben A
Psychooncology; 2008 Aug; 17(8):790-6. PubMed ID: 18613292
[TBL] [Abstract][Full Text] [Related]
11. Role of Heredity in Melanoma Susceptibility: A Primer for the Practicing Surgeon.
Abdo JF; Sharma A; Sharma R
Surg Clin North Am; 2020 Feb; 100(1):13-28. PubMed ID: 31753108
[TBL] [Abstract][Full Text] [Related]
12. Priority of Risk (But Not Perceived Magnitude of Risk) Predicts Improved Sun-Protection Behavior Following Genetic Counseling for Familial Melanoma.
Taber JM; Aspinwall LG; Drummond DM; Stump TK; Kohlmann W; Champine M; Cassidy P; Leachman SA
Ann Behav Med; 2021 Feb; 55(1):24-40. PubMed ID: 32415830
[TBL] [Abstract][Full Text] [Related]
13. A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public.
Smit AK; Espinoza D; Newson AJ; Morton RL; Fenton G; Freeman L; Dunlop K; Butow PN; Law MH; Kimlin MG; Keogh LA; Dobbinson SJ; Kirk J; Kanetsky PA; Mann GJ; Cust AE
Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):212-221. PubMed ID: 27702805
[TBL] [Abstract][Full Text] [Related]
14. Dermoscopic features of melanomas associated with MC1R variants in Spanish CDKN2A mutation carriers.
Cuéllar F; Puig S; Kolm I; Puig-Butille J; Zaballos P; Martí-Laborda R; Badenas C; Malvehy J
Br J Dermatol; 2009 Jan; 160(1):48-53. PubMed ID: 18795926
[TBL] [Abstract][Full Text] [Related]
15. Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlations.
Colombino M; Paliogiannis P; Pagliarello C; Cossu A; Lissia A; Satta R; Mazzoni L; Magi S; Sini MC; Manca A; Casula M; Doneddu V; Palmieri G; Stanganelli I
Eur J Dermatol; 2018 Apr; 28(2):149-156. PubMed ID: 29180316
[TBL] [Abstract][Full Text] [Related]
16. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
[TBL] [Abstract][Full Text] [Related]
17. Digital Dermoscopy Photographs Outperform Handheld Dermoscopy in Melanoma Diagnosis.
Mintsoulis D; Beecker J
J Cutan Med Surg; 2016 Nov; 20(6):602-605. PubMed ID: 27270098
[TBL] [Abstract][Full Text] [Related]
18. Multiple primary melanomas versus single melanoma of the head and neck: a comparison of genetic, diagnostic, and therapeutic implications.
Pollio A; Tomasi A; Pellacani G; Ruini C; Mandel VD; Fortuna G; Seidenari S; Ponti G
Melanoma Res; 2014 Jun; 24(3):267-72. PubMed ID: 24638154
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors of Subsequent Primary Melanomas in Austria.
Müller C; Wendt J; Rauscher S; Sunder-Plassmann R; Richtig E; Fae I; Fischer G; Okamoto I
JAMA Dermatol; 2019 Feb; 155(2):188-195. PubMed ID: 30566178
[TBL] [Abstract][Full Text] [Related]
20. Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk.
Aspinwall LG; Stump TK; Taber JM; Drummond DM; Kohlmann W; Champine M; Leachman SA
Transl Behav Med; 2018 Jan; 8(1):29-43. PubMed ID: 29385581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
